Advertisement

Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice

      Abstract

      Aims

      Vein graft endothelial damage is a key step in the development of neointimal hyperplasia, leading to vein graft failure. We sought to determine whether exogenous endothelial progenitor cells could promote vein graft re-endothelialization, and thereby ameliorate neointimal hyperplasia.

      Methods and results

      Carotid artery interposition grafting was performed with syngeneic inferior vena cavae in mice with severe combined immunodeficiency (SCID). Lineage-negative human umbilical cord blood (hUCB) cells (or medium alone) were injected into vein-grafted mice intra-operatively and 2 weeks post-operatively. In vein grafts from hUCB cell-injected mice, we found human HLA-expressing endothelial cells, as well as increased levels of VEGF and FGF-2. Furthermore, hUCB cells secreted VEGF and FGF-2 in vitro. The markedly enhanced endothelial regeneration, likely resulting from both direct engraftment and paracrine actions of hUCB cells, inhibited inflammatory response, diminished intimal cell proliferation, and reduced neointimal hyperplasia in the vein grafts.

      Conclusions

      hUCB cells may accelerate vein graft re-endothelialization via both direct differentiation into endothelial cells and release of paracrine factors to enhance endothelial regeneration and reduce inflammation. These data highlight a potential therapeutic role for cellular therapy in vessel injury.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zwolak R.M.
        • Adams M.C.
        • Clowes A.W.
        Kinetics of vein graft hyperplasia: association with tangential stress.
        J Vasc Surg. 1987; 5: 126-136
        • Eslami M.H.
        • Gangadharan S.P.
        • Belkin M.
        • et al.
        Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?.
        J Vasc Surg. 2001; 34: 923-929
        • Mann M.J.
        • Dzau V.J.
        Genetic manipulation of vein grafts.
        Curr Opin Cardiol. 1997; 12: 522-527
        • Zhang L.
        • Peppel K.
        • Brian L.
        • Chien L.
        • Freedman N.J.
        Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells.
        Arterioscler Thromb Vasc Biol. 2004; 24: 2277-2283
        • Dong C.
        • Crawford L.E.
        • Goldschmidt-Clermont P.J.
        Endothelial progenitor obsolescence and atherosclerotic inflammation.
        J Am Coll Cardiol. 2005; 45: 1458-1460
        • Asahara T.
        • Murohara T.
        • Sullivan A.
        • et al.
        Isolation of putative progenitor endothelial cells for angiogenesis.
        Science. 1997; 275: 964-967
        • Lin Y.
        • Weisdorf D.J.
        • Solovey A.
        • Hebbel R.P.
        Origins of circulating endothelial cells and endothelial outgrowth from blood.
        J Clin Invest. 2000; 105: 71-77
        • Vasa M.
        • Fichtlscherer S.
        • Aicher A.
        • et al.
        Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.
        Circ Res. 2001; 89: E1-E7
        • Hill J.M.
        • Zalos G.
        • Halcox J.P.
        • et al.
        Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.
        N Engl J Med. 2003; 348: 593-600
        • Murohara T.
        • Ikeda H.
        • Duan J.
        • et al.
        Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.
        J Clin Invest. 2000; 105: 1527-1536
        • Vaziri H.
        • Dragowska W.
        • Allsopp R.C.
        • et al.
        Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
        Proc Natl Acad Sci USA. 1994; 91: 9857-9860
        • Goodwin H.S.
        • Bicknese A.R.
        • Chien S.N.
        • et al.
        Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers.
        Biol Blood Marrow Transplant. 2001; 7: 581-588
        • Zhu S.
        • Liu X.
        • Li Y.
        • Goldschmidt-Clermont P.J.
        • Dong C.
        Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells.
        Arterioscler Thromb Vasc Biol. 2007; 27: 113-119
        • Rauscher F.M.
        • Goldschmidt-Clermont P.J.
        • Davis B.H.
        • et al.
        Aging, progenitor cell exhaustion, and atherosclerosis.
        Circulation. 2003; 108: 457-463
        • Zhang L.
        • Hagen P.O.
        • Kisslo J.
        • Peppel K.
        • Freedman N.J.
        Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
        J Vasc Surg. 2002; 36: 824-832
        • Xu Q.
        • Zhang Z.
        • Davison F.
        • Hu Y.
        Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice.
        Circ Res. 2003; 93: e76-e86
        • Mayr U.
        • Zou Y.
        • Zhang Z.
        • et al.
        Accelerated arteriosclerosis of vein grafts in inducible NO synthase(−/−) mice is related to decreased endothelial progenitor cell repair.
        Circ Res. 2006; 98: 412-420
        • Sainz J.
        • Sata M.
        Maintenance of vascular homeostasis by bone marrow-derived cells.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1196-1197
        • Murugesan S.
        • Mousa S.A.
        • O’connor L.J.
        • Lincoln II, D.W.
        • Linhardt R.J.
        Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis.
        FEBS Lett. 2007; 581: 1157-1160
        • Zhang L.
        • Freedman N.J.
        • Brian L.
        • Peppel K.
        Graft-extrinsic cells predominate in vein graft arterialization.
        Arterioscler Thromb Vasc Biol. 2004; 24: 470-476
        • He T.
        • Smith L.A.
        • Harrington S.
        • et al.
        Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries.
        Stroke. 2004; 35: 2378-2384
        • Kong D.
        • Melo L.G.
        • Gnecchi M.
        • et al.
        Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries.
        Circulation. 2004; 110: 2039-2046
        • Jiang Y.
        • Jahagirdar B.N.
        • Reinhardt R.L.
        • et al.
        Pluripotency of mesenchymal stem cells derived from adult marrow.
        Nature. 2002; 418: 41-49
        • Hinokiyama K.
        • Valen G.
        • Tokuno S.
        • Vedin J.B.
        • Vaage J.
        Vein graft harvesting induces inflammation and impairs vessel reactivity.
        Ann Thorac Surg. 2006; 82: 1458-1464
        • Leonard E.J.
        • Skeel A.
        • Yoshimura T.
        Biological aspects of monocyte chemoattractant protein-1 (MCP-1).
        Adv Exp Med Biol. 1991; 305: 57-64
        • Tatewaki H.
        • Egashira K.
        • Kimura S.
        • et al.
        Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
        J Vasc Surg. 2007; 45: 1236-1243
        • Selzman C.H.
        • Miller S.A.
        • Zimmerman M.A.
        • et al.
        Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation.
        Am J Physiol Heart Circ Physiol. 2002; 283: H1455-H1461
        • Schepers A.
        • Eefting D.
        • Bonta P.I.
        • et al.
        Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
        Arterioscler Thromb Vasc Biol. 2006; : 2063-2069